Literature DB >> 14684615

Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.

Mark Hazel1, Robert C Cooksey, Deborah Jones, Glendon Parker, John L Neidigh, Bryan Witherbee, Eric A Gulve, Donald A McClain.   

Abstract

Overexpression of the rate-limiting enzyme for hexosamine synthesis (glutamine:fructose-6-phosphate amidotransferase) in muscle and adipose tissue of transgenic mice was previously shown to result in insulin resistance and hyperleptinemia. Explanted muscle from transgenic mice was not insulin resistant in vitro, suggesting that muscle insulin resistance could be mediated by soluble factors from fat tissue. To dissect the relative contributions of muscle and fat to hexosamine-induced insulin resistance, we overexpressed glutamine:fructose-6-phosphate amidotransferase 2.5-fold, specifically in fat under control of the aP2 promoter. Fasting glucose, insulin, and triglycerides were unchanged in the transgenic mice; leptin and beta-hydroxybutyrate levels were 91% and 29% higher, respectively. Fasted transgenic mice have mild glucose intolerance and skeletal muscle insulin resistance in vivo. In fasting transgenic mice, glucose disposal rates with hyperinsulinemia were decreased 27% in females and 10% in males. Uptake of 2-deoxy-D-glucose into muscle was diminished by 45% in female and 21% in male transgenics. Serum adiponectin was also lower in the fasted transgenics, by 37% in females and 22% in males. TNF alpha and resistin mRNA levels in adipose tissue were not altered in the fasted transgenics; levels of mRNA for leptin were increased and peroxisome proliferator-activated receptor gamma decreased. To further explore the relationship between adiponectin and insulin sensitivity, we examined mice that have been refed for 6 h after a 24-h fast. Refeeding wild-type mice resulted in decreased serum adiponectin and increased leptin. In transgenic mice, however, the regulation of these hormones by refeeding was lost for adiponectin and diminished for leptin. Refed transgenic female and male mice no longer exhibited decreased serum adiponectin in the refed state, and they were no longer insulin resistant as by lower or unchanged insulin and glucose levels. We conclude that increased hexosamine levels in fat, mimicking excess nutrient delivery, are sufficient to cause insulin resistance in skeletal muscle. Changes in serum adiponectin correlate with the insulin resistance of the transgenic animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684615     DOI: 10.1210/en.2003-0812

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 2.  Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony.

Authors:  Mark A Herman; Barbara B Kahn
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Lactation Versus Formula Feeding: Insulin, Glucose, and Fatty Acid Metabolism During the Postpartum Period.

Authors:  Maria A Ramos-Roman; Majid M Syed-Abdul; Beverley Adams-Huet; Brian M Casey; Elizabeth J Parks
Journal:  Diabetes       Date:  2020-05-08       Impact factor: 9.461

Review 4.  Hexosamines, insulin resistance, and the complications of diabetes: current status.

Authors:  Maria G Buse
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01       Impact factor: 4.310

Review 5.  Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.

Authors:  Krithika Vaidyanathan; Lance Wells
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

6.  Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway.

Authors:  Robert C Cooksey; Donald A McClain
Journal:  Amino Acids       Date:  2010-07-24       Impact factor: 3.520

7.  Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1.

Authors:  Tiina A Jokela; Katri M Makkonen; Sanna Oikari; Riikka Kärnä; Elina Koli; Gerald W Hart; Raija H Tammi; Carsten Carlberg; Markku I Tammi
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

8.  Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.

Authors:  Chithra Keembiyehetty; Dona C Love; Katryn R Harwood; Oksana Gavrilova; Marcella E Comly; John A Hanover
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

9.  Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response.

Authors:  Brent A Penque; April M Hoggatt; B Paul Herring; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2013-01-11

Review 10.  Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.

Authors:  Chin Fen Teo; Edith E Wollaston-Hayden; Lance Wells
Journal:  Mol Cell Endocrinol       Date:  2009-09-30       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.